Generation of primary cells from ADPKD and normal human kidneys

• Published in: Methods in Kidney Cell Biology Part A Vol. 153; pp. 1 - 23
• Main Authors: Wallace, Darren P, Reif, Gail A
• Format: Book Chapter Journal Article
• Language: English
• Published: United States Elsevier Science & Technology 2019
• Subjects: Cell Line; Epithelial Cells; Humans; Kidney - cytology; Kidney - pathology; Mutation; Nephrectomy; Polycystic Kidney, Autosomal Dominant - genetics; Polycystic Kidney, Autosomal Dominant - pathology; Polycystic Kidney, Autosomal Dominant - surgery; Primary Cell Culture - instrumentation; Primary Cell Culture - methods; TRPP Cation Channels - genetics; Renal epithelial cells; In vitro models; Cysts; Tissue isolation; Autosomal dominant polycystic kidney disease
• ISBN: 0128170824; 9780128170823
• ISSN: 0091-679X
• DOI: 10.1016/bs.mcb.2019.05.005

Autosomal dominant polycystic kidney (ADPKD) is a common genetic disorder characterized by the presence of numerous fluid-filled cysts that lead to a progressive decline in renal function. Cystic tissues and primary cyst epithelial cells obtained from discarded human ADPKD kidneys provide unique biomaterials for the investigation of cellular mechanisms involved in cyst growth and changes in the microenvironment adjacent to the cysts. ADPKD cells have been used to develop straightforward in vitro cell model assays to study events down-stream of the mutant proteins in carefully controlled experimental conditions, test specific hypotheses, and evaluate the cellular response to potential therapeutic drugs. Normal cadaver kidneys deemed unsuitable for transplantation and "non-involved" portions of nephrectomy specimens removed for the treatment of kidney cancer provide important control tissues and the source of primary normal human kidney (NHK) cells for comparison to ADPKD specimens. This chapter describes the methods used in the collection of cystic and non-cystic tissues from ADPKD and normal kidneys and the generation of primary cell cultures. We also highlight strengths and weaknesses of using immortalized isogenic normal and PKD mutant cell lines.